Docetaxel plus gemcitabine shows antitumour efficacy in patients with advanced NSCLC
- 3 Downloads
KeywordsLung Cancer Median Survival Docetaxel Cell Lung Cancer Gemcitabine
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
© Adis International Ltd 2001